For the first time WHO and UNICEF bring together the data on sanitation coverage and investment, and how it impacts health, economies, and the environment. Citing evidence on what works from successful countries and global guidelines, WHO and UNICEF call for strong government leadership and investment in resilient sanitation services. The report charts an ambitious way forward following the SDG6 global acceleration framework themes of  governance, financing, capacity development, data and information, and innovation to achieve universal access to safe sanitation. 

This publication is a short summary report. Also read the full report 

The present report is submitted in response to General Assembly resolution 68/308. It provides a review of progress in the implementation of that resolution, focusing on the adoption and scaling up of interventions recommended by the World Health Organization in malaria-endemic countries. It provides an assessment of progress towards the 2015 global malaria targets, including Millennium Development Goal 6, targets set through the African Union and the World Health Assembly and goals set through the Global Malaria Action Plan developed by the Roll Back Malaria Partnership. It elaborates on the challenges limiting the full achievement of the targets and provides recommendations to ensure that progress is accelerated in the coming years.

Related documents

• General Assembly resolution 68/308 
• General Assembly resolution 69/325 

• WHO progress report on implementing UN General Assembly resolution 67/299

The main purpose of these guidelines is to assist national vector-borne disease control programmes, and other relevant agencies, in monitoring the durability of long-lasting insecticidal mosquito nets (LLINs) under operational conditions. The information derived by monitoring will be useful in planning the replacement of worn-out nets in an LN programme, making decisions to procure the most suitable LLINs for the setting and understanding the factors associated with the durability of LLIN products.

Related documents

• WHO recommendations for achieving universal coverage with long-lasting insecticidal nets in malaria control (2013)
• Concept note: a system to improve value for money in LLIN procurement through market competition based on cost per year of effective coverage (2011)
• WHO guidance note for estimating the longevity of long-lasting insecticidal nets in malaria control (2013)

The World Health Organization (WHO) first published guidance for national tuberculosis control programmes on managing tuberculosis in children (hereafter called “the Guidance”) in 2006. The Guidance follows the principles of a public health approach aimed at optimizing outcomes, including the quality of life and survival, of children with tuberculosis; it also serves as a reference tool for countries to adopt and adapt according to their national circumstances.

The aim of this revised guideline is to establish standards for high-quality treatment of tuberculosis in children by providing evidence-based recommendations while considering the risks and benefits, acceptability, feasibility, cost and financial implications.

This report – the first of its kind – takes stock of the malaria situation and of continuing efforts to tackle the disease in Africa; it is based on a review of the best information available to WHO and UNICEF, from sample surveys and routine reports, at the end of 2002.

This report of a WHO Study Group on Malaria Vector Control and Personal Protection reviewed the current vector control strategies and their effectiveness in various operational and eco-epidemiological settings and identified challenges for implementation in different health systems.

This report also provides a basis for the development of a strategic framework for strengthening malaria vector control implementation.

This document provides an overview of surveillance strategies that Member States should consider as part of comprehensive national surveillance for COVID-19.  This document emphasises the need to adapt and reinforce existing national systems where appropriate and to scale-up surveillance capacities as needed.

This report focuses on countries in Asia, the Pacific, Americas, Middle East, and Europe because of their unique circumstance; many countries are on the brink of eliminating malaria while at the same time facing challenges that aren’t seen elsewhere in the malaria-endemic world.

While the disease burden has been declining in countries with fewer malaria cases and deaths, progress has been slower in countries where the bulk of the disease burden lies: India, Indonesia, Myanmar, Pakistan, and Papua New Guinea (which account for 89% of all malaria cases in the region).

The fight against malaria is further complicated by growing parasite resistance to antimalarial drugs. In recent years, artemisinin resistance in the Greater Mekong subregion has become a major and urgent concern. There is a limited window of opportunity to contain resistant parasites before they spread around the world.

WHO and the Roll Back Malaria (RBM) Partnership have made available global strategies to tackle both drug and insecticide resistance. The Global Plan for Artemisinin Resistance Containment was released in January 2011, while the Global Plan for Insecticide Resistance Management was issued in May 2012. WHO also launched the T3: Test. Treat. Track initiative in April 2012 to urge countries to scale up diagnostic testing, treatment, and surveillance for malaria.

With malaria designated as one of the key priorities on the UN Secretary General’s five-year action agenda (2012–2017), there is an unprecedented opportunity to end the unnecessary suffering caused by this disease.

The purpose of this Codex Diagnostic Tool is to provide a framework for countries to carry out a self-assessment of the current status of the national Codex programme. It is an assessment of the collective capacity of the programme made up of individuals, processes and institutions. This includes assessing the capacity to effectively plan and participate in Codex sessions, to contribute scientific and technical input, to use Codex texts as a basis for national regulation and standards as appropriate, and to ensure Codex related activities and management of the programme are integral parts of the food safety control system. Upon completion, the results should assist in the identification of areas in need of strengthening and capacity development.

Other available languages

• Arabic
• French
• Russian
• Spanish

The mandate of the INTERSUN Programme:

At the United Nations Conference on Environment and Development (UNCED) in 1992 it was declared under Agenda 21 that there should be activities on the effects of UV radiation. Specifically,

• to undertake as a matter of urgency, research on the effects on human health of increasing ultraviolet radiation reaching the earth’s surface as a consequence of depletion of the stratospheric ozone layer;
• and on the basis of the outcome of this research, to consider taking appropriate remedial measures to mitigate the above mentioned effects on human beings.

Below are the minutes of the annual meeting:

Progress Report 2015-2016 [pdf, 865kb]

Progress Report 2014-2015 [pdf, 683kb]

Progress Report 2013-2014 [pdf, 636kb]

Progress Report 2012-2013 [pdf, 569kb]

Progress Report 2011-2012 [pdf, 573kb]

Progress Report 2010-2011 [pdf, 315kb]

Progress Report 2009-2010 [pdf, 184kb]

Progress Report 2008-2009 [pdf, 153kb]

Progress Report 2007-2008 [pdf, 505kb]

Progress Report 2006-2007 [pdf, 539kb]

Progress Report 2004-2005 [pdf, 456kb]

Progress Report 2003-2004 [pdf, 99kb]

The African Summit on Roll Back Malaria was held in Abuja, Nigeria on 25 April 2000. It reflected a real convergence of political momentum, institutional synergy and technical consensus on malaria. By signing the Declaration the African leaders rededicated themselves to the principles and targets of the Harare Declaration of 1997. They committed themselves to an intensive effort to halve the malaria mortality for Africa's people by 2010, through implementing strategies and actions for Roll Back Malaria, as agreed at the Summit.

Fourth session of the Meeting of the Parties to the Protocol to Eliminate Illicit Trade in Tobacco Products

Geneva, Switzerland, 24–26 November 2025

MOP4

Malaria remains a leading cause of ill health, causing an estimated 243 million cases of clinical malaria and 863 thousand deaths. More than 85% of malaria cases and 90% of malaria deaths occur in Africa, south of Sahara. In Africa, the vast majority of cases and deaths occur in young children.

Key interventions currently recommended by WHO for the control of malaria are the use of insecticidal treated nets (ITNs) or indoor residual spraying (IRS) for vector control, and prompt access to diagnosis and treatment of clinical malaria. Intermittent Preventive Treatment in pregnancy (IPTp) is also recommended for pregnant women – a high-risk group in areas of high malaria transmission.

WHO is now recommending a new intervention against Plasmodium falciparum malaria: Intermittent Preventive Treatment for infants (IPTi) with sulphadoxine-pyrimethamine (IPTi-SP) is the administration of a full therapeutic course of SP delivered through the Expanded Programme on Immunization (EPI) at defined intervals corresponding to routine vaccination schedules – usually at 10 weeks, 14 weeks, and ~9 months of age – to infants at risk of malaria.

Related document

• Intermittent preventive treatment for infants using sulfadoxine-pyrimethamine (IPTi-SP) for malaria control in Africa: implementation field guide

Interim Guidance: Biomedical equipment for COVID-19 case management - inventory tool: Interim guidance

All countries with a WHO office have a Country Cooperation Strategy (CCS). CCSs are flexible to align with the national health planning cycle (generally 4-5 years).

After the WHO country office and the government finalize the CCS, the country office develops a CCS Brief. The 2-page brief is updated each year, in advance of the World Health Assembly. It summarizes:

•  The main features of the country context in relation to health, development and cooperation with partners;
•  WHO’s main work priorities with the country in the medium term; and
•  Key public health indicators, utilizing data from the WHO Global Health Observatory.